Green Synthesis of Bioactive Silver Nanoparticles from Fagopyrum esculentum Hulls
<b>Background/Objectives</b>: The use of food waste in nanomaterial development represents an efficient and sustainable strategy for producing value-added products. <b>Methods</b>: In this study, silver nanoparticles (AgNPs) were synthesized from the hydroethanolic and aqueous extracts of buckwheat (<i>Fagopyrum esculentum</i> Moench) hulls, under optimized conditions. The resulting AgNPs were characterized using spectroscopic and microscopic techniques. To evaluate their bioactivity, free radical scavenging assays, cytotoxicity assays against tumor and normal cells, and broth microdilution assays were conducted. <b>Results</b>: AgNPs, synthesized from the hydroethanolic and aqueous buckwheat hull extracts under optimized conditions, were small (mean diameters of 19.97 ± 7.86 and 5.55 ± 1.34 nm, respectively), well dispersed (polydispersity index values of 0.204 and 0.345, respectively), negatively charged, and stable (zeta potential values of -24.10 ± 6.73 and -23.5 ± 10.3 mV, respectively). The latter were more homogenous in shape, being predominantly spherical. Both samples of AgNPs demonstrated remarkable cytotoxic activity against A-375 human malignant melanoma cells (IC<sub>50</sub> values below 5 μg/mL). AgNPs derived from the hydroethanolic buckwheat hull extract suppressed the growth of methicillin-resistant <i>Staphylococcus aureus</i> ATCC 43300 and <i>Staphylococcus epidermidis</i> ATCC 12228, with minimum inhibitory concentration (MIC) values of 37.50 and 4.68 μg/mL, respectively. AgNPs derived from the aqueous buckwheat hull extract exhibited higher free radical scavenging activity (EC<sub>50</sub> values of 132.6 ± 0.3 and 77.40 ± 3.52 μg/mL in the 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assays, respectively). <b>Conclusions</b>: AgNPs synthesized from the buckwheat hull extracts demonstrated notable potential as antimelanoma and antibacterial agents.
Authors
- Ana Clara Aprotosoaie (ORCID: https://orcid.org/0000-0002-6303-2320)
- Liviu Săcărescu (ORCID: https://orcid.org/0000-0002-6543-0277)
- C. Rîmbu (ORCID: https://orcid.org/0000-0003-0982-0040)
- Andreia Corciovă (ORCID: https://orcid.org/0000-0003-4061-2143)
- Irina Macovei (ORCID: https://orcid.org/0000-0002-2827-3217)
- Gabriela Vochița (ORCID: https://orcid.org/0000-0002-0876-473X)
- Krystyna Skalicka‐Woźniak (ORCID: https://orcid.org/0000-0002-9313-5929)
- Simon Vlad Luca (ORCID: https://orcid.org/0000-0003-0904-0060)
- Anca Miron (ORCID: https://orcid.org/0000-0002-0353-4564)
Institutions
- Medical University of Lublin (PL)
- Centre National de la Recherche Scientifique (FR)
- Grigore T. Popa University of Medicine and Pharmacy (RO)
- "Ion Ionescu de la Brad" Iasi University of Life Sciences (RO)
- National Institute of Research and Development for Biological Sciences (RO)
- Institut de Chimie Organique et Analytique (FR)
- Institutul de Chimie Macromoleculară Petru Poni
Publication Details
- Journal
- Pharmaceutics
- Published
- 2025-08-28
- DOI
- https://doi.org/10.3390/pharmaceutics17091124
- Primary Topic
- Seed and Plant Biochemistry
- Type
- article
- Field-Weighted Citation Impact
- 0.00